| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1537-2995.1998.38398222865.X |
| P698 | PubMed publication ID | 9563401 |
| P2093 | author name string | E J Lee | |
| C A Schiffer | |||
| R Sridhara | |||
| J M Kendall | |||
| C B Sarkodee-Adoo | |||
| P433 | issue | 3 | |
| P304 | page(s) | 229-235 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | The relationship between the duration of platelet storage and the development of transfusion reactions | |
| P478 | volume | 38 |
| Q35792449 | Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? |
| Q43092210 | Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions |
| Q35109407 | Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes |
| Q40594585 | Analysis of 516 reports of reactions after the transfusion of labile blood products |
| Q33769745 | Considerations in the selection of a platelet component: apheresis versus whole blood-derived |
| Q74107507 | Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction |
| Q37552707 | Descriptions of acute transfusion reactions in the teaching hospitals of kermanshah university of medical sciences, iran |
| Q74107514 | Detection of nucleic acid sequences from bacterial species with molecular genetic methods |
| Q40638359 | Diagnostic difficulties of transfusion incidents due to bacterial contamination: report of two cases |
| Q83017103 | Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis |
| Q43629600 | Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. |
| Q47385021 | Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial |
| Q40628811 | Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations |
| Q24240558 | Interventions for preventing allergic and febrile non-haemolytic transfusion reactions |
| Q33835138 | Leukocyte reduction of blood components: public policy and new technology |
| Q33361167 | Optimizing platelet transfusion therapy |
| Q24234953 | Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions |
| Q73288183 | Plasma and lipids from stored platelets cause acute lung injury in an animal model |
| Q35122220 | Risks associated with transfusion of cellular blood components in canada |
| Q37012102 | Scratching the surface of allergic transfusion reactions |
| Q46975056 | The effect of cromoglycate on time-dependent histamine and serotonin concentrations in stored blood products |
| Q35184743 | The quality of platelets after storage for 7 days |
| Q35091355 | Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets |
| Q87329613 | Transfusion-related acute lung injury |
| Q62090516 | Transfusión de plaquetas, ¿concentrados procedentes de un único o de múltiples donantes? |
| Q40541294 | Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions |
Search more.